story of the week
Ribociclib Plus Endocrine Therapy Improves Overall Survival in Patients With Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine